Ann Arbor, MINCT04008121Now EnrollingIRB Ready

Retinopathy Clinical Trial in Ann Arbor, MI

Access cutting-edge retinopathy treatment through this early phase 1 clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.

Sponsored by MediBeacon

Quick Self-Assessment

See if you qualify for this Ann Arbor location

Preparing your pre-screening questions…

Expert Care in Ann Arbor

Access retinopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related retinopathy treatment provided free

Apply for This Ann Arbor Location

Check if you qualify for this retinopathy clinical trial in Ann Arbor, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Ann Arbor

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Ann Arbor site if eligible
  4. 4Begin participation

About This Retinopathy Study in Ann Arbor

The objective of this study is to evaluate the safety and image quality of the investigational dye, MB-102, compared to the control dye (fluorescein sodium) in healthy and diseased eyes using fluorescent angiography for retinal vascular disease diagnosis and monitoring.

Sponsor: MediBeacon

Who Can Participate

Inclusion Criteria

Age \> 18 years - male or female
Eligible female non-pregnant participants who are either not of child-bearing potential or willing to utilize adequate contraception during the trial
Males must be willing to practice abstinence or utilize adequate contraception from MB-102 dosing day to at least 7 days post dose
Participants willing to comply with study requirements
Participants who have signed an informed consent form At least 5 participants will have a current history of retinal or choroidal vascular diseases.

Exclusion Criteria

Women who are pregnant, lactating or planning to become pregnant during the study, or women who are of childbearing potential unwilling to utilize adequate contraception
Participation in another interventional trial within 30 days of treatment or concurrently enrolled in any other medical research study which could impact the results of the study
History of drug or alcohol abuse within the past year
History of severe allergic hypersensitivity reactions (unacceptable adverse events) or anaphylactoid reaction to any allergen including drugs, MB-102 and fluorescein sodium or other related products (intolerance to a drug is not considered a drug allergy).
Prior history of seizures
Current visually significant cataracts or other ophthalmic conditions that would limit appropriate collection of fundus photographs
Site personnel immediately associated with the study or their immediate family members
Unable to tolerate ophthalmologic imaging
Any characteristics which, in the opinion of the investigator, makes the participant a poor candidate for participation in the clinical trial (e.g. unstable medical condition including cardiovascular disease, or other conditions considered clinically significant or unstable by the Principal Investigator)
Prior enrollment and dosing in this study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Ann Arbor?

Yes, this clinical trial (NCT04008121) has an active research site in Ann Arbor, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Retinopathy Treatment Options in Ann Arbor, MI

If you're searching for retinopathy treatment options in Ann Arbor, MI, this clinical trial (NCT04008121) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Ann Arbor research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced retinopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all retinopathy clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Ann Arbor, MI

See all essential tremor clinical trials recruiting in Ann Arbor — not just this study.

Browse Essential Tremor Trials in Ann Arbor →

Browse More Trials by Condition

Essential Tremor TrialsDiabetic Retinopathy TrialsAll Conditions →

Ready to Join in Ann Arbor?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Ann Arbor, MI